EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $256,000 | -4.5% | 30,859 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $268,000 | -20.0% | 30,859 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $335,000 | -9.0% | 30,859 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $368,000 | -30.4% | 30,859 | -6.4% | 0.00% | 0.0% |
| Q2 2020 | $529,000 | +37.8% | 32,959 | +7.7% | 0.00% | 0.0% |
| Q2 2019 | $384,000 | +140.0% | 30,614 | +135.7% | 0.00% | +100.0% |
| Q1 2019 | $160,000 | +100.0% | 12,991 | 0.0% | 0.00% | – |
| Q4 2018 | $80,000 | -41.6% | 12,991 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $137,000 | -22.2% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $176,000 | -23.5% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $230,000 | -43.2% | 12,991 | -59.8% | 0.00% | -50.0% |
| Q4 2017 | $405,000 | -34.1% | 32,291 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $615,000 | +26.3% | 32,291 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $487,000 | +119.4% | 32,291 | +148.6% | 0.00% | +100.0% |
| Q1 2017 | $222,000 | +41.4% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $157,000 | +23.6% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $127,000 | -4.5% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $133,000 | -15.3% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $157,000 | -24.5% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $208,000 | +24.6% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $167,000 | -46.3% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $311,000 | +28.0% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $243,000 | -0.8% | 12,991 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $245,000 | -65.2% | 12,991 | -50.0% | 0.00% | -50.0% |
| Q3 2014 | $704,000 | – | 25,982 | – | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2013 | $202,000 | +4.7% | 9,700 | +102.1% | 0.00% | 0.0% |
| Q3 2013 | $193,000 | +144.3% | 4,800 | +71.4% | 0.00% | – |
| Q2 2013 | $79,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |